Stay updated on Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page.

Latest updates to the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page
- CheckyesterdayChange DetectedA site-wide NIH notice appears above the blocked study record, announcing a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check8 days agoChange DetectedThe site footer revision identifier was updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check15 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden message.SummaryDifference0.2%

- Check36 days agoChange DetectedAccess to the study record has been replaced by a 403 Forbidden page, effectively hiding the study details and related navigation. The change represents a site-level access issue that prevents users from viewing the trial information on this page.SummaryDifference18%

- Check43 days agoChange DetectedAdded Tel Litwinsky, Ramat - GAN, Israel, 5265601 to the list of study sites. Removed Qiryat Krinitzi, Ramat - GAN, Israel, 5265601 from the list of study sites.SummaryDifference0.0%

- Check50 days agoChange DetectedTel Litwinsky, Ramat - GAN, Israel, 5265601 was removed from the study locations. Qiryat Krinitzi, Ramat - GAN, Israel, 5265601 was added to the study locations.SummaryDifference0.0%

Stay in the know with updates to Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page.